Skip to content

Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors

Effects of Hands-on-Healing vs. Touch for Fatigue and Inflammation in Breast Cancer Survivors

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00440089
Enrollment
76
Registered
2007-02-26
Start date
2005-10-31
Completion date
2009-09-30
Last updated
2010-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Cancer, Fatigue, Breast Cancer, Healing, Energy Healing, Complementary, Alternative, Immune, Cytokine, Hormone, Cortisol, Placebo, Mock Healing

Brief summary

This randomized controlled trial examines the efficacy of hands-on-healing for fatigue and immune function in breast cancer survivors. Participants may be randomized to one of three groups: hands-on-healing, touch alone, or a control group.

Detailed description

Please see our website at http://healing.ucsd.edu for detailed information on the study.

Interventions

BEHAVIORALHands-on-Healing

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Premenopausal and postmenopausal women between the ages of 18 to 70 years. * Ability to give informed consent. * Breast cancer survivors who have undergone surgery, including lumpectomy and simple or total mastectomy, followed by chemotherapy or a combination of chemo- and radio-therapy. We have elected to study survivors instead of patients actively undergoing treatment to alleviate subject burden and risk during this protocol. * Stage I to III breast cancer survivors. * Breast cancer survivors who have finished their chemotherapy and/or radiotherapy at least one month prior to 60 months prior. * Breast cancer survivors with above-normative levels of fatigue.

Exclusion criteria

* Breast cancer patients who are currently receiving or who are scheduled to receive radiation or chemotherapy during the course of this intervention study. * Patients with current major depression, current or history of prior bipolar illness, currently on psychotropic medications. * Patients with other diseases that are known to induce fatigue (e.g., thyroid disorder; sleep disorders). * Patients with other inflammatory diseases that affect cytokine levels. * Patients with a history of other cancers, and stage IV breast cancer. * Patients undergoing current chemotherapy and/or radiotherapy. * Men with breast cancer. * Substance abuse/dependence. * Continued use of another biofield-based intervention (e.g., Reiki, Qi-Gong, Healing Touch, Therapeutic Touch, Johrei).

Design outcomes

Primary

MeasureTime frame
Multiple Fatigue Symptom Inventory

Secondary

MeasureTime frame
Inflammatory Immune Markers
Diurnal Cortisol Variability

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026